The selective mu opioid receptor antagonist, alvimopan, improves delayed GI transit of postoperative ileus in rats

Bagnol, 1997, Cellular localization and distribution of the cloned mu and kappa opioid receptors in rat gastrointestinal tract, Neuroscience, 81, 579, 10.1016/S0306-4522(97)00227-3 Barquist, 1996, Neuronal pathways involved in abdominal surgery-induced gastric ileus in rats, Am. J. Physiol., 270, R888 Boeckxstaens, 1999, Activation of an adrenergic and vagally-mediated NANC pathway in surgery-induced fundic relaxation in the rat, Neurogastroenterol. Motil., 11, 467, 10.1046/j.1365-2982.1999.00172.x Brix-Christensen, 1997, Endogenous morphine levels increase following cardiac surgery as part of the antiinflammatory response?, Int. J. Cardiol., 62, 191, 10.1016/S0167-5273(97)00229-5 Brown, 1985, The use of quaternary narcotic antagonists in opiate research, Neuropharmacology, 24, 181, 10.1016/0028-3908(85)90072-3 Brown, 1993, The effect of an opiate receptor antagonist on the ileal brake mechanism in the rat, Pharmacology, 47, 230, 10.1159/000139102 Bueno, 1988, Action of opiates on gastrointestinal function, Baillieres Clin. Gastroenterol., 2, 123, 10.1016/0950-3528(88)90024-3 Burleigh, 1981, Subcutaneous morphine reduces intestinal propulsion in rats partly by a central action, Eur. J. Pharmacol., 75, 283, 10.1016/0014-2999(81)90555-0 Camilleri, 2005, Alvimopan, a selective peripherally acting μ-opioid antagonist, Neurogastroenterol. Motil., 17, 157, 10.1111/j.1365-2982.2005.00640.x Cassel, 2005, [3H]Alvimopan binding to the μ opioid receptor: comparative binding kinetics of opioid antagonists, Eur. J. Pharmacol., 520, 29, 10.1016/j.ejphar.2005.08.008 Daubert, 2000, Inhibition of opioid receptor-mediated [35S]GTPγS binding by ADL 8-2698, a potent opioid receptor antagonist, Soc. Neurosci. Abstr., 26, 283.13 De Jonge, 2003, Postoperative ileus is maintained by intestinal immune infiltrates that activate inhibitory neural pathways in mice, Gastroenterology, 125, 1137, 10.1016/S0016-5085(03)01197-1 De Winter, 1997, Effect of adrenergic and nitrergic blockade on experimental ileus in rats, Br. J. Pharmacol., 120, 464, 10.1038/sj.bjp.0700913 Ferraz, 1995, Opioid and nonopioid analgesic drug effects on colon contractions in monkeys, Dig. Dis. Sci., 40, 1417, 10.1007/BF02285185 Frantzides, 1990, Effects of morphine on colonic myoelectric and motor activity in subhuman primates, Am. J. Physiol., 258, G247 Fuder, 1995, Heteroreceptor-mediated modulation of noradrenaline and acetylcholine release from peripheral nerves, Rev. Physiol. Biochem. Pharmacol., 126, 265, 10.1007/BFb0049778 Gutstein, 2006, Opioid analgesics, 547 Holzer, 1992, Participation of capsaicin-sensitive afferent neurons in gastric motor inhibition caused by laparotomy and intraperitoneal acid, Neuroscience, 48, 715, 10.1016/0306-4522(92)90414-W Jacoby, 1987, The effect of Phe-Met-Arg-Phe-NH2 (FMRFamide) on morphine-induced inhibition of colonic propulsive motility in mice, Neurosci. Lett., 83, 128, 10.1016/0304-3940(87)90228-X Kalff, 2000, Role of inducible nitric oxide synthase in postoperative intestinal smooth muscle dysfunction in rodents, Gastroenterology, 118, 316, 10.1016/S0016-5085(00)70214-9 Kalff, 2003, Intra-abdominal activation of a local inflammatory response within the human muscularis externa during laparotomy, Ann. Surg., 237, 301, 10.1097/01.SLA.0000055742.79045.7E Kaufman, 1988, Role of opiate receptors in the regulation of colonic transit, Gastroenterology, 94, 1351, 10.1016/0016-5085(88)90673-7 Kotake, 1989, Variations in demethylation of N-methylnaltrexone in mice, rats, dogs, and humans, Xenobiotica, 19, 1247, 10.3109/00498258909043176 Kromer, 1988, Endogenous and exogenous opioids in the control of gastrointestinal motility and secretion, Pharmacol. Rev., 40, 121 Kurz, 2003, Opioid-induced bowel dysfunction: pathophysiology and potential new therapies, Drugs, 63, 649, 10.2165/00003495-200363070-00003 Langer, 1997, 25 years since the discovery of presynaptic receptors: present knowledge and future perspectives, Trends Pharmacol. Sci., 18, 95, 10.1016/S0165-6147(96)01034-6 Little, 2001, ADL 8-2698, a GI restricted opioid antagonist, blocks the antisecretory and colorectal transit effects of morphine and loperamide, Soc. Neurosci. Abstr., 27, 907.2 Liu, 2001, ADL 8-2698, a trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine, prevents gastrointestinal effects of intravenous morphine without affecting analgesia, Clin. Pharmacol. Ther., 69, 66, 10.1067/mcp.2001.112680 Livingston, 1990, Postoperative ileus, Dig. Dis. Sci., 35, 121, 10.1007/BF01537233 Luckey, 2003, Corticotropin-releasing factor receptor 1-deficient mice do not develop postoperative gastric ileus, Gastroenterology, 125, 654, 10.1016/S0016-5085(03)01069-2 Miller, 1981, Accurate measurement of intestinal transit in the rat, J. Pharmacol. Methods, 6, 211, 10.1016/0160-5402(81)90110-8 Mizuta, 1999, Nitrergic regulation of colonic transit in rats, Am. J. Physiol., 277, G275 Patierno, 2004, Abdominal surgery induces mu opioid receptor endocytosis in enteric neurons of the guinea-pig ileum, Neuroscience, 123, 101, 10.1016/j.neuroscience.2003.08.052 Porreca, 1984, Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse, J. Pharmacol. Exp. Ther., 230, 341 Schmidt, 2001, Alvimopan* (ADL 8-2698) is a novel peripheral opioid antagonist, Am. J. Surg., 182, 27S, 10.1016/S0002-9610(01)00784-X Tache, 1999, Corticotropin-releasing factor and the brain-gut motor response to stress, Can. J. Gastroenterol., 13, 18A, 10.1155/1999/375916 Taguchi, 2001, Selective postoperative inhibition of gastrointestinal opioid receptors, N. Engl. J. Med., 345, 935, 10.1056/NEJMoa010564 Uemura, 2004, Magnitude of abdominal incision affects the duration of postoperative ileus in rats, Surg. Endosc., 18, 606, 10.1007/s00464-003-8161-6 Weisbrodt, 1980, Effect of morphine sulfate on intestinal transit and myoelectric activity of the small intestine of the rat, J. Pharmacol. Exp. Ther., 214, 333 Wolff, 2004, Alvimopan, a novel, peripherally acting μ opioid antagonist. Results of a multicenter, randomized, double-blind, placebo-controlled, Phase III trial of major abdominal surgery and postoperative ileus, Ann. Surg., 240, 728, 10.1097/01.sla.0000141158.27977.66 Yokotani, 1998, Involvement of mu-receptor in endogenous opioid peptide-mediated inhibition of acetylcholine release from the rat stomach, Jpn. J. Pharmacol., 78, 93, 10.1254/jjp.78.93 Yokotani, 1993, Release of endogenous acetylcholine from a vascularly perfused rat stomach in vitro; inhibition by M3 muscarinic autoreceptors and alpha-2 adrenoceptors, J. Pharmacol. Exp. Ther., 266, 1190 Yoshida, 2000, Effect of surgical stress on endogenous morphine and cytokine levels in the plasma after laparoscopoic or open cholecystectomy, Surg. Endosc., 14, 137, 10.1007/s004649900085 Yuan, 2000, Methylnaltrexone: investigation of clinical applications, Drug Dev. Res., 50, 133, 10.1002/1098-2299(200006)50:2<133::AID-DDR1>3.0.CO;2-8 Zimmerman, 1994, LY246376 dihydrate, Drugs Future, 19, 1078, 10.1358/dof.1994.019.12.276933